Sotera Health Director GTCR INVESTMENT XI LLC Sells 8M Shares at $15.11/Share.
PorAinvest
martes, 9 de septiembre de 2025, 8:47 pm ET1 min de lectura
SHC--
The proceeds from the offering will not be received by the company itself, but rather will be used to cover the expenses related to the offering under the company's Amended and Restated Registration Rights Agreement. Goldman Sachs & Co. LLC is acting as the underwriter for the offering, and the securities have been registered with the Securities and Exchange Commission (SEC) [2].
Sotera Health, a leading global provider of end-to-end sterilization solutions and lab testing services, is committed to its mission of "Safeguarding Global Health." The company operates through three main businesses: Sterigenics®, Nordion®, and Nelson Labs®. The secondary offering is expected to help the company maintain its financial health and continue to support its growth initiatives [1].
This announcement comes at a time when the healthcare industry is experiencing significant growth, driven by increasing demand for sterilization services and lab testing solutions. Sotera Health's strong market position and commitment to innovation make it a key player in this sector.
References:
[1] https://seekingalpha.com/news/4492056-sotera-health-announces-secondary-offering-of-common-stock
[2] https://finance.yahoo.com/news/sotera-health-announces-secondary-offering-205700324.html
Sotera Health Co. [SHC] has recently disclosed that Director and 10% Owner GTCR Investment XI LLC has executed a transaction involving the sale of 8,000,000 shares at a price of $15.11 per share on September 5, 2025.
Sotera Health Company (NASDAQ: SHC) has announced a secondary offering of 20 million shares of its common stock, with a par value of $0.01 per share. The offering, which is set to take place on September 5, 2025, is being executed by certain affiliates of Warburg Pincus and GTCR as selling stockholders. Notably, GTCR Investment XI LLC, a 10% owner and director of the company, has agreed to sell 8 million shares at a price of $15.11 per share [2].The proceeds from the offering will not be received by the company itself, but rather will be used to cover the expenses related to the offering under the company's Amended and Restated Registration Rights Agreement. Goldman Sachs & Co. LLC is acting as the underwriter for the offering, and the securities have been registered with the Securities and Exchange Commission (SEC) [2].
Sotera Health, a leading global provider of end-to-end sterilization solutions and lab testing services, is committed to its mission of "Safeguarding Global Health." The company operates through three main businesses: Sterigenics®, Nordion®, and Nelson Labs®. The secondary offering is expected to help the company maintain its financial health and continue to support its growth initiatives [1].
This announcement comes at a time when the healthcare industry is experiencing significant growth, driven by increasing demand for sterilization services and lab testing solutions. Sotera Health's strong market position and commitment to innovation make it a key player in this sector.
References:
[1] https://seekingalpha.com/news/4492056-sotera-health-announces-secondary-offering-of-common-stock
[2] https://finance.yahoo.com/news/sotera-health-announces-secondary-offering-205700324.html

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema



Comentarios
Aún no hay comentarios